期刊文献+

留置PICC导管对非血液系统恶性肿瘤化疗患者血液流变学影响及其临床意义 被引量:9

The impact of PICC on the blood rheology of nonhematologic malignancy patients
暂未订购
导出
摘要 目的比较非血液系统恶性肿瘤患者化疗前后血液流变学的变化趋势,并探讨留置PICC导管对非血液系统肿瘤化疗患者血液流变学的影响。方法分别测定37例留置PICC导管(试验组)及36例未留置PICC导管(对照组)非血液系统恶性肿瘤患者化疗前后血液流变学指标,观察化疗后的血液流变学变化趋势,并对两组患者的血液流变学指标进行比较分析。结果对照组化疗后全血黏度值(切变率1、5、50、100、200s-1)、全血低切相对指数、全血高切相对指数、全血低切还原黏度、全血高切还原黏度、红细胞刚性指数均低于化疗前(P<0.05);试验组化疗后所有血液流变学指标与化疗前比较,差异均不具有显著性(P>0.05);试验组化疗后所有血液流变学指标与对照组化疗后比较,差异均不具有显著性(P>0.05)。结论留置PICC导管对非血液系统恶性肿瘤化疗患者血液流变学没有影响。 【Objective】To study the trends in blood rheology in patients with malignant tumor after chemotherapy and to explore the effect of PICC on hemorheology in patients with non-hematologic malignancies chemotherapy.【Methods】Were measured in 37 cases PICC(the experimental group) and 36 cases did not undergo(the control group) hemorheological changes in patients with non-hematologic malignancies before and after chemotherapy,observation the non-hematologic malignancies patients after chemotherapy changes in the hemarheology trends,and the situation of the hemorheology changes in patients with non-hematologic malignancies were compared between the two groups.【Results】The control group after chemotherapy,great majority hemorheological indicators were lower than those before chemotherapy(P 0.05);there were no hemorheological indicators differences between before and after chemotherapy in the group of row PICC(P 0.05);there were no hemorheological indicators differences between the two groups of patients after chemotherapy(P 0.05).【Conclusion】Rowed PICC on blood rheology have no effect in chemotherapy patients with non-hematologic malignancies.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2013年第6期102-105,共4页 China Journal of Modern Medicine
基金 湖南省科技厅资助(No:2010SK3107)
关键词 非血液系统恶性肿瘤 化疗 血液流变学 PICC non-hematological malignancies chemotherapy hemorheology PICC
  • 相关文献

参考文献6

二级参考文献72

  • 1梁添玉,张振香.下肢深静脉血栓的预防及护理[J].护理研究(下半月),2005,19(1):165-166. 被引量:59
  • 2李彬先,李瑞昆.恶性肿瘤病人血液流变学指标检测的临床价值[J].中国血液流变学杂志,2005,15(4):596-597. 被引量:20
  • 3[1]Baron JA,Gridley G,Weiderpass E,et al.Venous thromboembolism and cancer[J]. Lancet,1998,351(9109):1077-1080.
  • 4[2]Dintenfass L. Hemorheology of cancer metastasis; An example of malignant melanoma survival time and abnormality of blood viscosity of factors[J].Clin Hemorheol,1992, 12(2):259-271.
  • 5[3]Kubota T, Andoh K, Sedakata H, et al. Tissue factor released from leukemic cell[J]. Thromb Haemostas,1991,65(1):59-63.
  • 6[4]Edwards RL,Rickles FR.Thrombosis and cancer[A]. In:Hull R,Pineory GF.Disorders of thrombosis[M]. Philadelphia:Saunders,1996,12(4):374-384.
  • 7[5]Cornugz J,Pearson SD,Creager MA,et al.Importancee of findings on the initial evaluation of cancer in individual with symptomatic idiopathic deep venous thrombosis[J].Ann Intern Med,1996,12(5):785.
  • 8[6]Naschitz JE,Yeshurun D,Lev LM.Thromboembolism in cancer: changing trends[J]. Cancer,1993,71(4):1384-1390.
  • 9[1]Lip GH,Chin BSP,Blam AD.Cancer and the prothrombotoc state.Lancet Oncol,2002,3 (1):27
  • 10[2]Prandoni P,Falanga A,Piccioli A.Cancer and venous thromboembolism.Lancet Oncol,2005,6:401

共引文献151

同被引文献75

引证文献9

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部